Panel clarifies intervention rules for 'mental health only' nurses, allowing more flexibility on testing and duration

The Intervention Evaluation Committee of the Board of Registered Nursing discussed on May 5 how the board’s intervention program will treat ‘‘mental health only’’ participants, clarifying that those individuals are not automatically subject to the uniform standards that apply to participants with substance use disorders.

Lori Melby, introduced by the executive officer to present the informational briefing, said the board and legal staff reviewed whether mental‑health‑only participants must follow the same uniform standards and concluded they do not. “When you have a mental‑health‑only participant, you do not have to do the drug screening,” Melby said, adding that the committee retains discretion to apply portions of the uniform standards if clinically warranted.

Why it matters: uniform Standard No. 12 contains a three‑year documented sobriety requirement for substance‑use participants. Melby told members the IEC can recommend early successful completion — for example at one or two years — when clinical evidence shows stability, and that recommendations may include tailored work‑site monitoring to protect the public while supporting an earlier return to full duties.

Committee members pressed Melby on initial testing. A member asked whether a baseline urine drug test should be required when the clinical assessment lists prior substance use. Melby said the IEC may request a baseline screen if the provider notes or history indicate reason for concern but may rely on clinical records when reliable documentation exists. She noted that testing is expensive and often paid out of pocket by participants, and urged evidence‑based decision making: “If you already have good reliable information, you don’t want to say, ‘Well, I just want to make sure,’” she said.

Melby also warned against overreacting to single positive tests for legally available substances such as alcohol or marijuana. A solitary positive result, she said, must be considered in context: clinical documentation and provider assessment should drive whether the committee treats a case as a substance use disorder and applies the uniform standards.

Melby described alternatives to traditional mutual‑aid meetings (for example, Codependents Anonymous or other therapeutic groups) and reiterated that IEC recommendations should be individualized. She said that if evidence emerges during monitoring that suggests a dual diagnosis, the IEC can then adopt the substance‑use pathway and associated uniform standards.

The briefing was informational; the committee did not adopt a new written regulation at the meeting. Staff asked IEC members to review the IEC guide and offer feedback to help staff flesh out guidance and possible regulatory changes. The meeting recessed to closed session at 9:34 a.m. to consider applicant and participant matters. The next IEC meeting was scheduled for July 8, 2026, in Sacramento.